Slate Medicines
Boston, US · Founded 2024 · Delaware corporation · 9 employees on LinkedIn · 2 known investors
Slate Medicines is a clinical-stage biotechnology company. The page profiles an executive but provides limited detail on the company's specific therapeutic focus.
Founders & leadership
SP
Sara PachecoExecutive
NB
Neil BuckleyExecutive
GF
Gregory Frank OakesExecutive
GO
Gregory OakesChief Executive Officer and Board Director
Board
TL
Tim LohoffBoard director
CX
Cindy XiongBoard director
AL
Investors · 2
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2026
▶$10MraisedMar 2026 · 6 investors · PharmaceuticalsRule 506(b)
▶$10MraisedMar 2026 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sara PachecoExecutive Officer
- Tim LohoffDirector
- Cindy XiongDirector
- Neil BuckleyExecutive Officer, Director
- Gregory Frank OakesExecutive Officer
- Andrew LevinDirector
- Offering amount
- $130M
- Amount sold
- $10M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Milestone Pharmaceuticals4 shared keywordsMilestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.
Slate Bio4 shared keywordsSlate Bio develops regulatory T cell (Treg) therapies for treating autoimmune diseases. The company focuses on advancing immunology treatments for patients with autoimmune conditions.
Rhythm Pharmaceuticals3 shared keywordsRhythm Therapeutics develops precision medicines for rare neuroendocrine diseases, particularly those affecting the melanocortin-4 receptor pathway. The company's lead product, IMCIVREE (setmelanotide), is FDA-approved to treat severe obesity caused by genetic impairments in the hypothalamus.
Honeybee Health3 shared keywordsHoneybee Health is a mail-order pharmacy based in California that fills prescription and over-the-counter medications, selling generic drugs at transparent, low prices without insurance. It serves patients directly as well as telehealth platforms and practitioners through a prescription fulfillment partnership program, and can also fill prescriptions for pets.
Companies competing with Slate Medicines for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Fulcrum, Slate Medicines sign merger agreementpharmaceutical-technology.com · Aug 2026Frequently asked questions
- What does Slate Medicines do?
- Slate Medicines is a clinical-stage biotechnology company. The page profiles an executive but provides limited detail on the company's specific therapeutic focus.
- Who are Slate Medicines's investors?
- Slate Medicines's investors include Foresite Capital, RA Capital.
- How much funding has Slate Medicines raised?
- Slate Medicines has disclosed $10M raised across 1 round.
- Where is Slate Medicines headquartered?
- Slate Medicines is headquartered in Boston, US.